EMEA-000316-PIP03-20

Table of contents

Key facts

Invented name
Entresto
Active substance
  • sacubitril
  • valsartan
Therapeutic area
Cardiovascular diseases
Decision number
P/0315/2020
PIP number
EMEA-000316-PIP03-20
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Film-coated tablet
  • Granules
Condition(s) / indication(s)
Prevention of heart failure
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited

E-mail: paediatric.enquiries@novartis.com
Tel. +41 613246715

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating